- Home
- CBOE vs MDLN Comparison
CBOE vs MDLN Comparison
Compare CBOE & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBOE | MDLN |
|---|---|---|
| Founded | 1973 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 30.7B |
| IPO Year | 2010 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CBOE | MDLN |
|---|---|---|
| Price | $279.48 | $34.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 27 |
| Target Price | ★ $315.64 | $44.60 |
| AVG Volume (30 Days) | 895.3K | ★ 6.8M |
| Earning Date | 10-30-2026 | 08-05-2026 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | ★ 44.52 | N/A |
| EPS | ★ 7.01 | 0.23 |
| Revenue | $2,229,100,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | N/A | $9.85 |
| Revenue Next Year | $3.70 | $7.82 |
| P/E Ratio | ★ $37.80 | $151.74 |
| Revenue Growth | ★ 239.31 | 11.47 |
| 52 Week Low | $227.15 | $31.49 |
| 52 Week High | $371.18 | $50.88 |
Technical Indicators
Market Signals| Indicator | CBOE | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 53.04 |
| Support Level | $274.15 | $32.47 |
| Resistance Level | $305.98 | $37.39 |
| Average True Range (ATR) | 9.21 | 1.14 |
| MACD | 0.50 | 0.34 |
| Stochastic Oscillator | 78.88 | 85.78 |
Price Performance
Historical ComparisonAbout CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.
About MDLN Medline Inc. Class A Common Stock
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.